Skip to main content
Premium Trial:

Request an Annual Quote

Applied DNA Sciences: Clay Shorrock

Clay Shorrock has been appointed as chief legal officer and executive director of business development at Applied DNA Sciences. He previously served as the company's in-house general and IP counsel from 2016 to 2019 and as outside general and IP counsel after that. Shorrock holds a JD with a concentration in IP from Seton Hall University Law School and a BA in biology from Franklin and Marshall College.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.